MedPath

ICG-99mTc-nanocolloid vs. 99mTc-nanocolloid en een intraoperatieve injectie van ICG voor de schildwachtklierprocedure van prostaat kanker.

Recruiting
Conditions
prostate cancer, sentinel lymph node
Registration Number
NL-OMON28336
Lead Sponsor
etherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI/AVL)
Brief Summary

van der Poel et al, Eur Urol 2012; Jeschke et al., Urology 2012

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
138
Inclusion Criteria

patients >18 years of age

- patients with histologically proven prostate cancer

Exclusion Criteria

- patients with a history of iodine allergy

- patients with a hyperthyroid or thyroidal adenoma

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of tumor positive lymph nodes.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath